Inhibition of autophagy enhances apoptosis induced by proteasome inhibitor bortezomib in human glioblastoma U87 and U251 cells

Glioblastoma is the most aggressive cerebral gliomas. Despite advances in therapies, the prognosis is still very poor. Therefore, novel therapeutic strategies are required. As a proteasome inhibitor, bortezomib has shown its efficacy as an active antitumor agent against a variety of tumors. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xudong, Li, Weiming, Wang, Chunlan, Leng, Xiangyang, Lian, Shulin, Feng, Jingbin, Li, Jinliang, Wang, Hailiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840293/
https://www.ncbi.nlm.nih.gov/pubmed/24104452
http://dx.doi.org/10.1007/s11010-013-1835-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840293/
https://www.ncbi.nlm.nih.gov/pubmed/24104452
http://dx.doi.org/10.1007/s11010-013-1835-z

Ejemplares similares